LYRA
Lyra Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.99 / 10
Netural
The technical framework scores 3.99/10, reflecting challenging technical structure. Strength in MACD Golden Cross provides support, but Long Lower Shadow and Long Upper Shadow indicate potential resistance. Overall technical bias leans cautious.
Analysis Checks(1/3)
Long Lower Shadow
Score2.07/10
Win Rate37.14%
Hist. Signals70
Avg Return11.95%
Score2.07/10
Win Rate37.14%
Hist. Signals70
Avg Return11.95%
MACD Golden Cross
Score8.2/10
Win Rate83.33%
Hist. Signals6
Avg Return66.75%
Score8.2/10
Win Rate83.33%
Hist. Signals6
Avg Return66.75%
Long Upper Shadow
Score1.71/10
Win Rate34.74%
Hist. Signals95
Avg Return5.75%
Score1.71/10
Win Rate34.74%
Hist. Signals95
Avg Return5.75%
Long Lower Shadow
Score2.07/10
Win Rate37.14%
Hist. Signals70
Avg Return11.95%
Score2.07/10
Win Rate37.14%
Hist. Signals70
Avg Return11.95%
Long Upper Shadow
Score1.71/10
Win Rate34.74%
Hist. Signals95
Avg Return5.75%
Score1.71/10
Win Rate34.74%
Hist. Signals95
Avg Return5.75%
MACD Golden Cross
Score8.2/10
Win Rate83.33%
Hist. Signals6
Avg Return66.75%
Score8.2/10
Win Rate83.33%
Hist. Signals6
Avg Return66.75%
Technical Analysis of LYRA?
- LYRA presents a Netural setup with a Technical Score of 3.99/10. Key technical indicators highlight an RSI of 36.99 and a MACD of 0.08, with the trend anchored by the 50-Day SMA at 3.04. Traders should monitor key support at 1.71 and resistance at 1.89.
